Ningbo Menovo Pharm Co Ltd (603538) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Ningbo Menovo Pharm Co Ltd stock ¥5.12, price ¥19.14, that is 73.2% below the price, quality 55 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Ningbo Menovo Pharm Co Ltd
603538 · SHGFar too expensive (fair value 73% below the price) and price moving sideways, but solid company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ¥10.01 – ¥68.50 · fair‑value band ¥3.61 – ¥6.66 · the ¥19.14 price screens above the ¥5.12 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Ningbo Menovo Pharm Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products.
Show moreShow less
It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. The company was founded in 2004 and is headquartered in Ningbo, China.
Stock analysis
Ningbo Menovo Pharm Co Ltd (603538) currently trades at ¥19.14, while our model-based Fair Value estimate is ¥5.12, 73% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ¥7.34 per share, and 1 of the 26 models we run sit above the ¥19.14 price.
Bear case: the Dividend Discount group reads lowest at ¥0.9400, and 25 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ¥3.61 (bear) to ¥6.66 (bull), the price of ¥19.14 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Healthcare sector.
Mixed Growth: Spin-off in 2022: revenue and profit before it include the divested business. Growth is measured afresh from 2022.
Ningbo Menovo Pharm Co Ltd reported revenue of 1.5B CNY in FY2025 versus 1.3B CNY in FY2021, a compound +4.5%/yr. Reported net income was 102M CNY in FY2025, compounding −8.0%/yr from FY2021.
Key figures
Market cap 6.7B CNY (≈ $1,000M) Small · P/E ratio 44.5 · P/S ratio 3.95 · EPS (TTM) ¥0.4300 · Dividend yield 0.6% · Net margin 6.9% · Return on equity 4.4% · Return on assets (EBIT) 4.1% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).
What moves the price
The share trades about 72% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −28% fair-value upside, at −73%, 603538 screens richer than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
603538 screens overvalued: fair value 73% below the price. Compare with Merck KGaA →
Compare Ningbo Menovo Pharm Co Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 605 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EBIT margin by industry
- P/S ratio by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $84.39 | $113.53 | +35% | vs 603538 |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.66 | ¥53.04 | +11% | vs 603538 |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,870 | ₹1,983 | +6% | vs 603538 |
| Haleon plc HLN | $9.20 | $8.47 | −8% | vs 603538 |
| Merck KGaA MRK | €150.75 | €108.83 | −28% | vs 603538 |
| Galderma Group GALD | CHF 187.15 | CHF 112.46 | −40% | vs 603538 |
| Takeda Pharmaceutical Company TAK | $21.59 | $11.23 | −48% | vs 603538 |
| Sandoz Group SDZ | CHF 83.00 | CHF 40.54 | −51% | vs 603538 |
| Teva Pharmaceutical Industries Limited TEVA | $42.57 | $20.74 | −51% | vs 603538 |
| Divi's Laboratories Limited DIVISLAB | ₹11,150 | ₹1,567 | −86% | vs 603538 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Ningbo Menovo Pharm Co Ltd (603538) overvalued or undervalued?
What is the fair value of 603538?
What is the quality score of 603538?
What is the price target for Ningbo Menovo Pharm Co Ltd (603538)?
What is the Ningbo Menovo Pharm Co Ltd stock forecast for 2026?
What is the revenue of Ningbo Menovo Pharm Co Ltd (603538)?
Does Ningbo Menovo Pharm Co Ltd pay a dividend?
How much is the dividend of Ningbo Menovo Pharm Co Ltd (603538) and when is the ex-dividend date?
What growth is priced into Ningbo Menovo Pharm Co Ltd (603538)?
What discount rate (WACC) does the fair value of 603538 use?
What is a reverse DCF?
How much growth has Ningbo Menovo Pharm Co Ltd (603538) delivered so far?
How fast is the sector of Ningbo Menovo Pharm Co Ltd (603538) growing?
What is the free cash flow yield of Ningbo Menovo Pharm Co Ltd (603538)?
What is the intrinsic value of Ningbo Menovo Pharm Co Ltd (603538)?
Is Ningbo Menovo Pharm Co Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 603538?
How much is Ningbo Menovo Pharm Co Ltd worth?
What do the bullish and bearish scenarios say about 603538?
What is the P/E ratio of 603538?
How solid is the balance sheet of Ningbo Menovo Pharm Co Ltd (603538)?
How far is 603538 from its 52-week high?
Which stocks are comparable to Ningbo Menovo Pharm Co Ltd?
Is Ningbo Menovo Pharm Co Ltd stock attractive at the current price?
How is the fair value of 603538 calculated?
Is it still worth investing in stocks now?
What is the share price of Ningbo Menovo Pharm Co Ltd (603538)?
What should I pay attention to with Ningbo Menovo Pharm Co Ltd right now?
Where does the earnings growth of Ningbo Menovo Pharm Co Ltd (603538) come from?
Key figures of Ningbo Menovo Pharm Co Ltd
How large is the market capitalisation of Ningbo Menovo Pharm Co Ltd (603538)?
What is the P/S ratio of Ningbo Menovo Pharm Co Ltd (603538)?
What are the earnings per share of Ningbo Menovo Pharm Co Ltd (603538)?
What is the dividend yield of Ningbo Menovo Pharm Co Ltd (603538)?
What is the net margin of Ningbo Menovo Pharm Co Ltd (603538)?
What is the return on equity of Ningbo Menovo Pharm Co Ltd (603538)?
What is the EBIT return on assets of Ningbo Menovo Pharm Co Ltd (603538)?
What is the operating margin of Ningbo Menovo Pharm Co Ltd (603538)?
How fast is revenue growing at Ningbo Menovo Pharm Co Ltd (603538)?
How fast are earnings growing at Ningbo Menovo Pharm Co Ltd (603538)?
How much net debt does Ningbo Menovo Pharm Co Ltd (603538) carry?
Watch Ningbo Menovo Pharm Co Ltd in the live analysis
One click puts Ningbo Menovo Pharm Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.